Publication & Citation Trends
Publications
72 total
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
Cited by 722
OpenAlex
Research Topics
Lung Cancer Diagnosis and Treatment
(17)
Lung Cancer Treatments and Mutations
(16)
Cancer Immunotherapy and Biomarkers
(13)
Antibiotics Pharmacokinetics and Efficacy
(10)
Palliative Care and End-of-Life Issues
(5)
Affiliations
Humboldt State University
Tartu University Hospital
Humboldt-Universität zu Berlin
North Estonia Medical Centre
Institute of Pharmacology